Key result
Polymorphisms near the PTPRD gene were associated with diastolic blood pressure response to atenolol and resistant hypertension across multiple ethnic groups.
Why the study?
Do single-nucleotide polymorphisms near the PTPRD gene influence blood pressure response to atenolol in patients with hypertension?
Observational (n=2,347)
Yes
Do single-nucleotide polymorphisms near the PTPRD gene influence blood pressure response to atenolol in patients with hypertension?
The PTPRD gene is a novel locus potentially associated with blood pressure response to atenolol and resistant hypertension across multiple ethnic groups.
Answers are grounded in this paper and cite their sources.
PTPRD variants may influence atenolol response; hypothesis-generating for pharmacogenomics in resistant hypertension.
OBJECTIVE: The aim of this study is to identify single-nucleotide polymorphisms (SNPs) influencing blood pressure (BP) response to the β-blocker atenolol. METHODS: Genome-wide association analysis of BP response to atenolol monotherapy was performed in 233 white participants with uncomplicated hypertension in the pharmacogenomic evaluation of antihypertensive responses study. Forty-two polymorphisms with P less than 10 for association with either diastolic or systolic response to atenolol monotherapy were validated in four independent groups of hypertensive individuals (total n = 2114). RESULTS: In whites, two polymorphisms near the gene PTPRD (rs12346562 and rs1104514) were associated with DBP response to atenolol (P = 3.2 × 10 and P = 5.9 × 10, respectively) with directionally opposite association for response to hydrochlorothiazide in another group of 228 whites (P = 0.0018 and P = 0.00012). A different polymorphism (rs10739150) near PTPRD was associated with response to atenolol in 150 black hypertensive individuals (P = 8.25 × 10). rs12346562 had a similar trend in association with response to bisoprolol (a different β-blocker) in 207 Finnish men in the genetics of drug responsiveness in essential hypertension study. In addition, an intronic single-nucleotide polymorphism (rs4742610) in the PTPRD gene was associated with resistant hypertension in whites and Hispanics in the international verapamil SR trandolapril study (meta-analysis P = 3.2 × 10). CONCLUSION: PTPRD was identified as a novel locus potentially associated with BP response to atenolol and resistant hypertension in multiple ethnic groups.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2015) conducted an observational in Hypertension (n=2,347). PTPRD gene polymorphisms was evaluated on Diastolic blood pressure response to atenolol (p=3.2 × 10). Polymorphisms near the PTPRD gene were associated with diastolic blood pressure response to atenolol and resistant hypertension across multiple ethnic groups.
Synapse has enriched 10 related papers. Consider them for comparative context: